​

Funding Round

Series B - CAMP4 Therapeutics

Series B - CAMP4 Therapeutics

Investment Firm

Overview

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Announced Date

Jul 20, 2022

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Enavate Sciences

Enavate Sciences

Enavate Sciences is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

6

Investor Name
Participant Investor5AM Ventures
Participant InvestorGaingels
Participant InvestorAndreessen Horowitz
Participant InvestorThe Kraft Group
Participant InvestorPolaris Partners

Round Details and Background

CAMP4 Therapeutics raised $100000000 on 2022-07-20 in Series B

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 31, 2018
Series A - CAMP4 Therapeutics
3-30.0M
Jan 13, 2020
Venture Round - CAMP4 Therapeutics
1-15.0M
Jun 15, 2021
Series A - CAMP4 Therapeutics
5-45.0M
Jul 20, 2022
Series B - CAMP4 Therapeutics
7-100.0M

Recent Activity

There is no recent news or activity for this profile.